Acute Hyperglycemia Worsens Hepatic Ischemia/Reperfusion Injury in Rats
- First Online:
- Cite this article as:
- Behrends, M., Martinez-Palli, G., Niemann, C.U. et al. J Gastrointest Surg (2010) 14: 528. doi:10.1007/s11605-009-1112-3
- 522 Downloads
Acute hyperglycemia is known to worsen ischemia/reperfusion (I/R) injury following myocardial infarction and stroke. We investigated whether acute hyperglycemia worsens injury and amplifies the inflammatory response evoked by hepatic I/R.
Rats were pretreated with an intraperitoneal injection of 25% glucose or 0.9% sodium chloride (10 ml/kg BW). Subsequently, rats underwent partial (70%) hepatic ischemia for 45 min. After 4 h of reperfusion, hepatic injury, oxidative stress, inflammation, and heat shock protein expression were assessed.
Liver injury was increased in the hyperglycemic group with alanine aminotransferase (ALT) and aspartate aminotransferease (AST) serum concentrations of 7,832 ± 3,374 and 10,677 ± 4,110 U/L compared to 3,245 ± 2,009 and 5,386 ± 3,393 U/L (p < 0.05 vs. control). Hyperglycemic I/R was associated with increased liver nitrotyrosine concentrations and increased neutrophil infiltration. I/R upregulated the protective heat shock proteins HSP32 and HSP70 in control animals, but this protective mechanism was inhibited by hyperglycemia: HSP32 expression decreased from 1.97 ± 0.89 (control) to 0.46 ± 0.13 (hyperglycemia), HSP70 expression decreased from 18.99 ± 11.55 (control) to 3.22 ± 0.56 (hyperglycemia), (expression normalized to sham, both p < 0.05 vs. control I/R).
Acute hyperglycemia worsens hepatic I/R injury by amplifying oxidative stress and the inflammatory response to I/R. The increase in injury is associated with a downregulation of the protective heat shock proteins HSP32 and HSP70.
KeywordsLiver Surgery Inflammatory response Neutrophils Metabolism
Acute hyperglycemia is frequently seen in hospitalized patients and induced by stressors such as acute illness and surgical trauma. Such transient increases in blood glucose concentrations may put patients at risk for adverse outcomes. Hyperglycemia independent of preexisting diabetes mellitus is an established risk factor for increased mortality and morbidity after cardiac surgery.1 Patients without a history of diabetes who were hyperglycemic at admission to the hospital had higher mortality and lower functional outcomes than normoglycemic and even hyperglycemic diabetic patients.2 Van den Berghe et al.3 showed that intensive insulin therapy (IIT) reduces in-hospital mortality in surgical intensive care unit patients by 34% with subsequent investigations confirming that maintaining normoglycemia rather than glycemia-independent effects of insulin is responsible for the beneficial effects of IIT.4,5 These findings emphasize the potential hazards of poor glucose control on patient outcome.
The detrimental effects of hyperglycemia do not require chronic exposure or preexisting diabetes. Animal models of acute hyperglycemia confirm the deleterious effects of even short episodes of hyperglycemia on cerebral6 and renal ischemia/reperfusion (I/R) injury.7 Proposed mechanisms for the detrimental effects of acute hyperglycemia are increased oxidative stress, an enhanced inflammatory response with cytokine activation8,9 and impaired blood flow with reperfusion.10
Diabetic mice have been shown to be more susceptible to liver ischemia,11,12 but so far, the effects of acute hyperglycemia on liver I/R injury have not been addressed. We therefore used a rat model of acute hyperglycemia to investigate its effects on hepatic I/R injury.
Material and Methods
All animal experiments were carried out with approval by the local committee on animal research. Animal care was in agreement with the National Institutes of Health guidelines for ethical research (NIH publication no. 80-123, revised 1985). Inbred male Lewis rats (Harlan, Indianapolis, IN, USA) were used for this study. Animals’ weights on arrival at our facility were 250–300 g. Animals had access to standard laboratory diet and were maintained on a light–dark cycle. They were fasted 12 h prior to the start of the experiments. Prior to the study, animals spent several days in the animal care facility for acclimatization.
The rats were divided into hyperglycemic and control group. In the hyperglycemic group (HG, n = 8), 2.5 g/kg glucose (25% solution) was injected intraperitoneally following the assessment of the baseline glucose serum concentration. The control group (CON, n = 8) received 10 ml/kg 0.9% saline instead. Thirty minutes later, rats were anesthetized with isoflurane. Following liver exposure through a midline incision and collection of blood samples, hepatic ischemia was induced. Applying a 70% liver ischemia model, the liver was mobilized, and vascular structures to the left and median lobe were identified and clamped for 45 min using a bulldog clamp. The unoccluded right and caudate lobe allow outflow from the splanchnic circulation, thus avoiding venous congestion. For the duration of hepatic ischemia, the abdominal cavity was closed with clamps. Rectal temperature was continuously assessed using an electronic thermometer (RSP TM-200D, Respiratory Support Products Inc., Santa Ana, CA, USA using a Mallinckrodt probe, cat no. 502-0401, Mallinckrodt Inc., St. Louis, MO, USA) and held constant at 37°C using a heating lamp.
Following reperfusion, the animals received 5 ml of normal saline intraperitoneally, and the incision was closed in two layers. Animals were killed following a 4 h observation period. Blood and tissue were harvested. All tissue was immediately frozen in liquid nitrogen and stored at −80°C until further processing.
Sham experiments (Sham, n = 5) served as reference for subsequent analysis. Sham experiments were identical to control I/R experiments except that hepatic vessels were not clamped. Hyperglycemic sham experiments (HG Sham, n = 4) were added to the protocol to identify the effects of hyperglycemia alone.
Biochemical Markers of Liver Injury
Serum levels of aspartate aminotransferease (AST) and alanine aminotransferase (ALT) were determined at baseline and following 4 h of reperfusion. The analysis was done in the General Laboratory, San Francisco General Hospital, University of California, San Francisco.
Suzuki Score for the Assessment of Liver Damage Following Hepatic Ischemia/Reperfusion
Single cell necrosis
Intrahepatic Neutrophil Accumulation Assessment
Activity of myeloperoxidase (MPO), an enzyme stored in the azurophilic granules of neutrophils, was used to measure tissue neutrophil sequestration. We used a spectrophotometric method to assay tissue MPO activity. Frozen livers were thawed and extracted for MPO following homogenization and sonication. The assay is based on the oxidation of 3,3′,5,5′-tetramethyl benzydine by MPO in the presence of H2O2. Units of MPO activity were calculated using a standard curve derived from a MPO standard sample (Calbiochem, EMD Bioscience, La Jolla, CA, USA). MPO data are expressed as microunits per milligram of tissue per minute.
Protein Isolation and Western Blots
All steps for protein isolation were conducted at 4°C. Snap-frozen liver sections were homogenized in Tissue Protein Extraction Reagent (Pierce Biotechnology, Rockford, IL) containing 1 mm EDTA and 1:100 Protease Cocktail Inhibitor (Sigma, St. Louis, MO) and were centrifuged at 10,000×g for 5 min. The supernatant was aliquoted, snap-frozen, and stored at −80°C. Protein concentrations of liver homogenates were measured by the Pierce bicinchoninic acid protein assay with bovine serum albumin as the standard. Fifty micrograms of liver homogenates was separated on a Novex-NuPAGE 10% Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis gel (Invitrogen) and transferred to nitrocellulose membrane using the XCell SureLock system (Invitrogen). A mouse anti-heat shock protein 70 (HSP70) monoclonal antibody (SC-24) and a goat anti-actin antibody (SC-1616) from Santa Cruz Biotechnology (Santa Cruz, CA) were used. In addition, a mouse anti-heat shock protein 32 (HSP32) monoclonal antibody from Stressgen (Ann Arbor, MI), a mouse anti-nitrotyrosine antibody from Abcam Inc. (Cambridge, MA), and a rabbit anti-cleaved caspase-3 monoclonal antibody (CST 9661) from Cell Signaling Technology (Danvers, MA) were used for the Western blots. The membranes were incubated with a 1:100 or 1:1,000 dilution of the primary antibody followed by a 1:10,000-fold dilution of a secondary anti-mouse or anti-goat immunoglobulin G from Santa Cruz Biotechnology. Immunoreactive proteins were developed using SuperSignal West Dura (Pierce Biotechnology) and visualized on the FluorChem 5500 Imaging system from Alpha Innotech (San Leandro, CA). Band intensities were quantified via spot densitometry.
All data are presented as mean ± SD. Comparison between study groups was performed using analysis of variance with post hoc Dunnett correction, with normoglycemic sham animals serving as controls. Comparison of the two ischemic groups alone was done using a two-tailed unpaired t test. p values < 0.05 were considered as being statistically significant.
Serum Marker of Liver Injury
Nitrotyrosine concentrations after 4 h of reperfusion were higher in hyperglycemic animals (1.63 ± 0.54-fold when compared to control animals (1.00 ± 0.30), p < 0.05) indicating increased oxidative stress resulting in nitration of tyrosine residues of proteins by peroxynitrite.
Heat Shock Protein activation
Acute hyperglycemia during hepatic ischemia amplified the inflammatory response and resulted in elevated transaminase concentrations following I/R. The elevated serum glucose concentration at the start of ischemia seemed to be responsible for the increase in injury, as there was a strong correlation between serum glucose concentrations before ischemia and transaminase concentration after 4 h of reperfusion. We used a transient model of hyperglycemia starting only shortly before ischemia. Serum glucose concentrations were still higher in hyperglycemic animals at the end of the 4 h reperfusion period, albeit the graph (Fig. 1) clearly demonstrates a declining trend.
Hepatic I/R has been reported to result in hepatocyte death by two different pathways, necrosis and apoptosis. Whether apoptotic or necrotic cell death predominates following liver I/R has been the subject of debate. Based on terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, it was suggested that sinusoidal endothelial cells and then subsequently hepatocytes undergo apoptosis but rarely necrosis following 60 min of liver ischemia.15 However, a later study applying a very similar ischemia model found only few apoptotic cells and predominantly necrosis following 60 min of ischemia when combining TUNEL with morphological criteria.16 A subsequent review emphasized that apoptosis and necrosis share features and mechanisms that can make discrimination between both forms of cell death very challenging. In particular, the TUNEL assay is not suited to differentiate between necrosis and apoptosis, since DNA fragmentation was reported in apoptosis as well as necrosis.17
In the present study, histological assessment of the liver samples after 4 h of reperfusion could not reliably distinguish between apoptotic and necrotic cell death. A longer reperfusion could potentially facilitate histological analysis, but 4 h of reperfusion was chosen to enable the detection of inflammatory mediators. As a result, the histological scores were basically identical in both experimental groups, in spite of serologic evidence for increased necrotic cell death in hyperglycemic animals. The higher transaminase concentrations measured in the hyperglycemic group after 4 h of reperfusion reflect increased cellular breakdown due to necrosis with release of intracellular enzymes. Apoptosis maintains the barrier function of the cell membrane and would contribute only to a minor extent to elevated transaminase concentrations. Caspase-3 activation is considered the most reliable method for the detection of apoptosis.14 We assessed caspase-3 activation to quantify the amount of apoptotic cell death and found higher apoptosis scores in the control group. The lower caspase-3 activation in the hyperglycemic group may be further evidence that necrosis, not apoptosis, is the preferential form of cell death in hyperglycemic conditions.
Hyperglycemia per se is known to increase oxidative stress and to cause a proinflammatory state.8 Furthermore, hyperglycemia has been shown to amplify the inflammatory response caused by stressors such as LPS administration.18 Our results support the hypothesis that the mechanisms responsible for increased ischemic injury by hyperglycemia are the amplification of oxidative stress and of the inflammatory response normally seen with I/R. The increased concentration of nitrotyrosine containing protein is an established marker for severe oxidative stress. Reactive oxygen species, such as the superoxide radical, react with NO to form the more potent peroxynitrite species, which then subsequently nitrate tyrosine residues of proteins, leading to inactivation of key cellular proteins, DNA damage, and eventually cell death.19 While Kupffer cell-induced oxidative stress is considered the first step in I/R injury,20 it is followed by a profound inflammatory response that is largely responsible for the extent of I/R injury. This inflammatory response culminates in the hepatic accumulation of neutrophils, which directly damage hepatocytes by releasing oxidants and proteases. The MPO assay confirmed an increased neutrophil infiltration in the liver tissue of hyperglycemic animals. This neutrophil migration and infiltration is initiated by the production and release of cytokines such as tumor necrosis factor alpha and interleukin-6. Earlier studies demonstrated that hyperglycemia enhances cytokine production in response to stress.21
A surprising finding of the present investigation was the downregulation of HSP32 and HSP70 in hyperglycemic animals undergoing I/R. Hepatic I/R normally results in upregulation of HSPs, and the observed effects in livers from hyperglycemic animals differ distinctly from the situation in kidneys7 and the brain,22 where hyperglycemic I/R injury is associated with an increased activation of HSPs. We could demonstrate in sham experiments that hyperglycemia alone was not responsible for the downregulation of HSPs (data not shown) but that the combination of hyperglycemia and I/R is required to block or even suppress HSP activation. Since HSPs are one of the most potent protective mechanisms against I/R injury, it can be assumed that their suppression in hyperglycemic I/R contributes to the increased injury during acute hyperglycemia. Inhibition of HSP activation in response to ischemia has so far not been described in other organs and may represent a liver-specific (mal-)adaptation to hyperglycemia: It has been described before that diabetes does inhibit hepatic HSP70 activation by heat stress,23 although subsequent studies did not confirm this finding.24,25
The mechanism responsible for the downregulation of HSPs remains to be defined. The expression of the heat shock genes encoding the different HSPs is regulated by heat shock transcription factors (HSFs), which are normally bound to HSPs within the cytosol. When cells are exposed to stress, HSFs are phosphorylated and form trimers that enter the nucleus and bind the heat shock elements located within the promoter of heat shock genes, thus initiating increased expression of HSPs.26 It has been hypothesized that, in diabetes, the activation of HSF is inhibited in insulin-sensitive tissue.27 In type 2 diabetic primates, livers had reduced HSP70 and HSP90 tissue concentrations that were related to 50% lower levels of the transcription factor heat shock factor 1.28 But again, these results are challenged by a study that showed similar heat shock factor 1 content in livers from control and streptozotocin treated rats following heat stress.24 Further interventional studies with activation of HSPs are planned to show whether the suppression of HSP activation is responsible for the worsened injury during hyperglycemia and whether activation of HSPs is capable of reversing such detrimental effects.
Acute hyperglycemia worsened liver injury as assessed by increased transaminase concentrations following hepatic I/R in rats. The effects of hyperglycemia on liver injury were associated with increased hepatic oxidative stress, an increased inflammatory response, and a suppression of HSP activation. These results, in spite of their descriptive nature, emphasize the need to better understand the role of hyperglycemia in organ injury, especially in clinical scenarios associated with a risk for ischemia. Glucose concentrations in this study were overall high, suggesting that glucose control may not need to be very aggressive to have beneficial effects. Preventing severe hyperglycemia alone may reduce I/R injury, thus avoiding the inherent risk of an IIT to cause undesired hypoglycemia.
This study was supported by grants from the Research Evaluation and Allocation Committee (REAC) of the University of California San Francisco (M.B.) and the Ministerio de Educacion y Ciencia, Spain (G.M.P.)
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.